The Phase 3 clinical trial will evaluate AstraZeneca’s AZD1222 Covid-19 coronavirus vaccine candidate, which was originally developed at Oxford University.
AstraZeneca Covid-19 Coronavirus Vaccine Begins Phase 3 Trial In U.S.
The Phase 3 clinical trial will evaluate AstraZeneca’s AZD1222 Covid-19 coronavirus vaccine candidate, which was originally developed at Oxford University.